Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovationPRNewsWire • 04/15/25
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025PRNewsWire • 04/10/25
Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholdersCNBC • 03/29/25
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply ChainInvestors Business Daily • 03/27/25
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of DirectorsPRNewsWire • 03/25/25
Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?Zacks Investment Research • 03/24/25
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discoveryPRNewsWire • 03/19/25
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive yearPRNewsWire • 03/06/25
ILMN Stock Might Rise From Collaboration With Broad Clinical LabsZacks Investment Research • 02/24/25
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biologyPRNewsWire • 02/24/25
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutionsPRNewsWire • 02/21/25
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) ConferencePRNewsWire • 02/18/25